Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
Clin Chem. 2023 Dec 1;69(12):1348-1360. doi: 10.1093/clinchem/hvad136.
Artificial intelligence (AI) has emerged as a promising and transformative tool in the field of urinalysis, offering substantial potential for advancements in disease diagnosis and the development of predictive models for monitoring medical treatment responses.
Through an extensive examination of relevant literature, this narrative review illustrates the significance and applicability of AI models across the diverse application area of urinalysis. It encompasses automated urine test strip and sediment analysis, urinary tract infection screening, and the interpretation of complex biochemical signatures in urine, including the utilization of cutting-edge techniques such as mass spectrometry and molecular-based profiles.
Retrospective studies consistently demonstrate good performance of AI models in urinalysis, showcasing their potential to revolutionize clinical practice. However, to comprehensively evaluate the real clinical value and efficacy of AI models, large-scale prospective studies are essential. Such studies hold the potential to enhance diagnostic accuracy, improve patient outcomes, and optimize medical treatment strategies. By bridging the gap between research and clinical implementation, AI can reshape the landscape of urinalysis, paving the way for more personalized and effective patient care.
人工智能(AI)在尿液分析领域已经成为一种有前途和变革性的工具,为疾病诊断的进步和监测医疗治疗反应的预测模型的发展提供了巨大的潜力。
通过对相关文献的广泛研究,本综述说明了 AI 模型在尿液分析的多个不同应用领域中的重要性和适用性。它涵盖了自动化尿液测试条和沉淀物分析、尿路感染筛查,以及尿液中复杂生化特征的解释,包括使用质谱和基于分子的谱等先进技术。
回顾性研究一致表明 AI 模型在尿液分析中的表现良好,展示了它们在改变临床实践方面的潜力。然而,要全面评估 AI 模型的实际临床价值和疗效,需要进行大规模的前瞻性研究。这些研究有可能提高诊断准确性,改善患者的预后,并优化治疗策略。通过研究与临床实践之间的衔接,人工智能可以重塑尿液分析的格局,为更个性化和有效的患者护理铺平道路。